Home › Nevro - I Remain Cautious After A Successful Debut For This Pain Relief Company
 

Keywords :   


Nevro - I Remain Cautious After A Successful Debut For This Pain Relief Company

2014-11-12 01:05:10| Furniture - Topix.net

Shares jumped more than 50% as investors like the prospects for adoption of its chronic pain treatment within the US. Given the already high valuation in relation to a somewhat modest addressable market, I remain a bit cautious following the momentum seen already.

Tags: this company successful remain

Category:Consumer Goods and Services

Latest from this category

All news
15.11Pre-Budget nerves blamed as UK growth slows
15.11Bitcoin hacker sentenced to five years in prison
15.11Europe's flying taxi dreams falter as cash runs short
14.11UK must rebuild post-Brexit relations with EU, says Bank boss
14.11'I spend 30 a week on baby milk because I can't breastfeed'
14.11The Onion buys Alex Jones's Infowars at auction
14.11Meta fined 798m over 'unfair' Facebook Marketplace
14.11Meta fined 798m over 'unfair' Facebook Marketplace
Consumer Goods and Services »
15.11 119
15.11
15.11
15.11Snowpeak SDE-001 M
15.11DVD5
15.113Dio Free Space
15.11
15.11Dr.
More »